Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
Gori A, Trabattoni D, Bandera A, Saresella M, Marchetti G, Gazzola L, Biasin M, Rhodes J, McDade H, Panebianco R, Galli M, Moroni M, Ferrante P, Thomas N, Franzetti F, Bray D, Clerici M.
Gori A, et al.
Antivir Ther. 2004 Aug;9(4):603-14.
Antivir Ther. 2004.
PMID: 15456092
Clinical Trial.